COVID vaccine effectiveness against heart failure and blood clots in the veins and arteries was 22%, 53%, and 45%, respectively, in the month after SARS-CoV-2 infection.
Vaccines cut risk of post-COVID heart failure, blood clots for at least 6 months, data suggest
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows